FDA Drug Recalls

Recalls / Class II

Class IID-1556-2014

Product

VIVITROL (naltrexone for extended-release injectable suspension); 380 mg vial NDC 65757-300-01; RX Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451.

Brand name
Vivitrol
Generic name
Naltrexone
NDCs
65757-300, 65757-301
FDA application
NDA021897
Affected lot / code info
Batch Number: 412-3732AA; expiration date 07/2016 (NDC# 65757-302-02; Kit Pacaging Lot Number: 2013-021; expiration date 07/2016 (NDC# 65757-300-01.

Why it was recalled

Customer complaints for failure to deliver the dose.

Recalling firm

Firm
Alkermes, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
852 Winter St, N/A, Waltham, Massachusetts 02451-1420

Distribution

Quantity
4,364 vials
Distribution pattern
Nationwide

Timeline

Recall initiated
2014-03-04
FDA classified
2014-08-22
Posted by FDA
2014-09-03
Terminated
2014-12-22
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1556-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Vivitrol · FDA Drug Recalls